Taken together, our results indicate that sex does not modify Alzheimer’s disease clinical outcomes and biomarker trajectories in adults with Down syndrome, except for the association between sex and APOE ɛ4 haplotype. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.